Idiopathic pulmonary arterial hypertension

Area of Science:

• Cardiovascular Research
• Pulmonary Medicine
• Animal Modeling

Background:

• Pulmonary arterial hypertension (PAH) is a severe, progressive disease leading to right heart failure and early mortality.
• Despite advances, current management of PAH offers substantial improvements but not a cure.
• Animal models have been crucial for understanding PAH pathobiology and developing treatments.

Purpose of the Study:

• To review the role of animal models in advancing PAH research.
• To highlight the limitations of current models in fully recapitulating human PAH.
• To emphasize the need for novel models, particularly for idiopathic PAH (IPAH).

Main Methods:

• Review of existing literature on animal models of pulmonary hypertension (PH).
• Analysis of insights gained from animal models into PAH pathobiology.
• Discussion of the challenges in modeling idiopathic PAH (IPAH).

Main Results:

• Animal models provide valuable insights into cellular pathways of PAH development and progression.
• Current models do not completely replicate the complexity of human PAH.
• Idiopathic PAH (IPAH) presents unique modeling challenges due to undefined etiology.

Conclusions:

• Animal models have significantly contributed to the progress in PAH management.
• Further development of animal models is essential for understanding PAH causes and risk factors.
• New models that more closely mimic IPAH pathophysiology are needed for improved therapeutic strategies.